Streetbeat News

Stock Prices

ABBV

HARP

Harpoon Therapeutics Inc's (NASDAQ:HARP) stock is trading lower after AbbVie Inc (NYSE:ABBV) decided not to exercise its exclusive license option within the Development and Option Agreement regarding Harpoon's HPN217 program. The termination of this agreement will take effect on October 12, 2023. This decision means that the HPN217 program will continue to be owned exclusively by Harpoon.

Portfolio Pulse from Vandana Singh

September 14, 2023 | 3:31 pm

HCA

HCA Healthcare (NYSE:HCA) has outperformed the market over the past 10 years, producing an average annual return of 19.85%. If an investor had bought $100 of HCA stock 10 years ago, it would be worth $633.02 today.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 3:30 pm

HUM

Humana (NYSE:HUM) has outperformed the market over the past 15 years, producing an average annual return of 17.23%. If an investor had bought $1000 of HUM stock 15 years ago, it would be worth $11,165.32 today. The company currently has a market capitalization of $58.16 billion.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 3:30 pm

NOC

Northrop Grumman Inc.'s (NYSE:NOC) stock price is currently at $426.43, after a 0.03% increase. However, the stock has fallen by 0.64% over the past month and by 12.11% over the past year. The company's P/E ratio is lower than the aggregate P/E of the Aerospace & Defense industry, which could indicate that the stock is undervalued or that shareholders do not expect the stock to perform well in the future.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 3:30 pm

AMZN

GOOG

GOOGL

PINS

Amazon has introduced several enhancements to its platform to improve customer search results and shopping decisions, intensifying competition with Google and Pinterest. These include visual search with text integration, augmented reality for home item visualization, sales trend information, a 'Find-on-Amazon' feature, and effortless reordering of previous purchases. Amazon's shares traded higher by 0.18% at $145.12 on the last check Thursday.

Portfolio Pulse from Anusuya Lahiri

September 14, 2023 | 3:26 pm

MSFT

Goldman Sachs analyst Kash Rangan reiterated a Buy rating on Microsoft Corp (NASDAQ:MSFT) with a price target of $400. Rangan sees potential for Microsoft's EPS to double by FY27, backed by AI and cloud adoption. He also projected revenue of $233.80 billion and EPS of $10.93 in FY24. Microsoft's shares traded higher by 0.51% at $337.79 on the last check Thursday.

Portfolio Pulse from Anusuya Lahiri

September 14, 2023 | 3:24 pm

AAPL

ADBE

AMZN

ARM

GOOG

META

MSFT

NVDA

TSLA

The article discusses the IPO of Arm Holdings (ARM), which designs chips used by many semiconductor manufacturers. The IPO was 10 times oversubscribed, indicating a potential rise in stock price. The article also mentions the use of generative AI by Amazon (AMZN) and Adobe (ADBE), and the ECB's interest rate hike. Economic data shows a hotter economy than consensus, with inflation at the producer level and retail sales exceeding expectations. Positive money flows are observed in Apple (AAPL), Amazon (AMZN), Alphabet (GOOG), Meta Platforms (META), Microsoft (MSFT), NVIDIA (NVDA), and Tesla (TSLA).

Portfolio Pulse from The Arora Report

September 14, 2023 | 3:22 pm

INFY

Infosys Inc.'s stock has increased by 6.54% over the past month and 4.03% over the past year. The company's P/E ratio is 25.0, lower than the IT Services industry average of 31.23, which could indicate that the stock is undervalued. However, a low P/E ratio could also suggest weak growth prospects or financial instability.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 3:15 pm

ASX

ASE Technology Holding Co. reported higher revenue for August, leading to an increase in its share price.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 3:10 pm

MRNA

Moderna's shares are trading higher following the recommendation by the EMA Committee for Medicinal Products for Human Use for the authorization of the company's updated COVID-19 vaccine in the EU.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 3:09 pm